4Biocapital
also invests · investor profileLondon, GB · 1 known investors
4BIO Capital is an investment firm focused on early-stage advanced therapies targeting chronic disease. The team combines academic researchers, physician-scientists, and investment professionals with direct experience in gene therapy and clinical research.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- 4BIO CAPITAL LIMITED
- Company number
- 15797534
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 23 Jun 2024
- Registered office
- 66 Paul Street, London, EC2A 4NA
- Nature of business (SIC)
- 70229 — Management consultancy activities other than financial management
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 22 Jun 2026 · next due 6 Jul 2027
Current officers · 3
- Andrey Kozlov — director, appointed 23 Jun 2024
- Dmitry Kuzmin — director, appointed 23 Jun 2024
- Kyrylo Mudryy — director, appointed 23 Jun 2024
Source: Companies House public register · retrieved 8 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does 4Biocapital do?
- 4BIO Capital is an investment firm focused on early-stage advanced therapies targeting chronic disease. The team combines academic researchers, physician-scientists, and investment professionals with direct experience in gene therapy and clinical research.
- Who are 4Biocapital's investors?
- 4Biocapital's investors include Pathway Bioventures.
- Where is 4Biocapital headquartered?
- 4Biocapital is headquartered in London, GB.